TAVI: Ist das Verfahren eine Alternative bei Patienten ohne erhöhtes Operationsrisiko?

Zusammenfassung

Die kathetergestützte Aortenklappenimplantation (TAVI) hat sich als sichere und effektive Prozedur zur Behandlung der hochgradigen symptomatischen Aortenklappenstenose etabliert und wird mittlerweile auch bei Patienten niedrigen und intermediären Risikos eingesetzt. Die verfügbaren Studien hierzu umfassen mittlerweile mehr als 9000 Patienten mit sehr vielversprechenden Ergebnissen für das kathetergestützte Verfahren im Vergleich mit dem operativen Aortenklappenersatz. Inwieweit sich diese Ergebnisse auch über einen langfristigen Nachbeobachtungszeitraum bestätigen, bleibt derzeit noch abzuwarten. Auch darüber hinaus wird das interdisziplinäre Herzteam integraler Bestandteil der Indikationsstellung und Therapieplanung bleiben.

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved as a safe and effective treatment option for patients with severe symptomatic aortic stenosis and is increasingly being performed in low-risk patients. Data from randomized trials including more than 9000 patients demonstrate very promising outcomes after TAVI compared to surgical aortic valve replacement in this patient population. If these positive results sustain over long-term follow-up remains to be determined. Above all, the interdisciplinary heart team remains of paramount importance for decisions on treatment strategies in these patients with severe aortic stenosis.

Schlüsselwörter

Aortenklappenstenose - TAVI - AKE

Keywords

TAVI - TAVR - SAVR - aortic stenosis

• Literatur

• 1 Thaden JJ, Nkomo VT, Enriquez-Sarano M. The Global Burden of Aortic Stenosis. Prog Cardiovasc Dis 2014; 56: 565-571
• 2 Adams DH, Popma JJ, Reardon MJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med 2014; 370: 1790-1798
• 3 Smith CR, Leon MB, Mack MJ. et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med 2011; 364: 2187-2198
• 4 Gleason TG, Reardon MJ, Popma JJ. et al. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol 2018; 72: 2687-2696
• 5 Mack MJ, Leon MB, Smith CR. et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477-2484
• 6 Kapadia SR, Leon MB, Makkar RR. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485-2491
• 7 Leon MB, Smith CR, Mack M. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607
• 8 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2022; 43: 561-632
• 9 Otto CM, Nishimura RA, Bonow RO. et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e72-e227
• 10 Shahian DM, Jacobs JP, Badhwar V. et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1—Background, Design Considerations, and Model Development. Ann Thorac Surg 2018; 105: 1411-1418
• 11 Nashef SA, Roques F, Sharples LD. et al. Euroscore ii. Eur J Cardiothorac Surg 2012; 41: 734-745
• 12 Thyregod HGH, Jørgensen TH, Ihlemann N. et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024; 45: 1116-1124
• 13 Thyregod HGH, Steinbrüchel DA, Ihlemann N. et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015; 65: 2184-2194
• 14 Jørgensen TH, Thyregod HGH, Ihlemann N. et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021; 42: 2912-2919
• 15 Leon MB, Smith CR, Mack MJ. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-1620
• 16 Reardon MJ, Van Mieghem NM, Popma JJ. et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017; 376: 1321-1331
• 17 Van Mieghem NM, Deeb GM, Søndergaard L. et al. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA Cardiol 2022; 7: 1000-1008
• 18 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1695-1705
• 19 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med 2023; 389: 1949-1960
• 20 Forrest JK, Deeb GM, Yakubov SJ. et al. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. J Am Coll Cardiol 2023; 82: 2163-2165
• 21 Popma JJ, Deeb GM, Yakubov SJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1706-1715
• 22 Toff WD, Hildick-Smith D, Kovac J. UK TAVI Trial Investigators. et al. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA 2022; 327: 1875-1887
• 23 Blankenberg S, Seiffert M, Vonthein R. et al. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med 2024; 390: 1572-1583
• 24 Jørgensen TH, Thyregod HGH, Savontaus M. et al. Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial. Eur Heart J 2024; 45: 3804-3814
• 25 Ahmad Y, Howard JP, Arnold AD. et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J 2023; 44: 836-852
• 26 Rahman H, Ghosh P, Nasir F. et al. Short- and intermediate-term outcomes of transcatheter aortic valve replacement in low-risk patients: A meta-analysis and systematic review. Int J Cardiol Heart Vasc 2024; 53: 101458
• 27 Kolkailah A, Doukky R, Pelletier M. et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev 2019; (12) CD013319
• 28 Ahmed K, McVeigh T, Cerneviciute R. et al. Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis. BMC Nephrol 2018; 19: 323
• 29 Bruno F, D’Ascenzo F, Vaira MP. et al. Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis. Eur Heart J Qual Care Clin Outcomes 2021; 7: 143-153
• 30 Di Pietro G, Improta R, De Filippo O. et al. Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients: An Updated Metanalysis of Extended Follow-Up Randomized Controlled Trials. Am J Cardiol 2024; 224: 56-64
• 31 O’Hair D, Yakubov SJ, Grubb KJ. et al. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. JAMA Cardiol 2023; 8: 111-119